R&G PharmaStudies Co

R&G PharmaStudies Co EPS

The Earnings per Share (EPS) of R&G PharmaStudies Co (301333.SZ) as of Oct 21, 2026 is 1.42 CNY. In the previous year, Earnings per Share (EPS) was 1.45 CNY — a change of -2.37% (lower).

EPS

1.42CNY

YoY

-2.37%

Last updated:

Earnings per Share (EPS) of R&G PharmaStudies Co is 2025 1.42 CNY. Earnings per Share (EPS) of R&G PharmaStudies Co was 2024 1.45 CNY. It decreases by -2.37% lower compared to the previous year.

The R&G PharmaStudies Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
0.87 CNY
Jan 1, 2021
1.03 CNY
Jan 1, 2022
1.89 CNY
Jan 1, 2023
1.69 CNY
Jan 1, 2024
1.45 CNY
Jan 1, 2025
1.42 CNY
Jan 1, 2026 (e)
1.73 CNY
Jan 1, 2027 (e)
2.04 CNY
The R&G PharmaStudies Co EPS history
YEAREPSYoY
est2.04CNY+17.92%
est1.73CNY+22.05%
1.42CNY-2.37%
1.45CNY-14.25%
1.69CNY-10.46%
1.89CNY+84.02%
1.03CNY+18.37%
0.87CNY+1.46%
0.86CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

R&G PharmaStudies Co Stock analysis

What does R&G PharmaStudies Co do? R&G PharmaStudies Co Ltd, based in Beijing, China, provides clinical trial outsourcing services within the Health Care sector. The company offers a range of services including clinical trial operations, site management, biological sample testing, data management, statistical analysis, consulting, and clinical pharmacology. With 1,926 employees, it operates primarily in the domestic Chinese market and was listed on the stock market on 2 August 2022. R&G PharmaStudies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R&G PharmaStudies Co stock

Earnings per Share (EPS) of R&G PharmaStudies Co is 1.42 CNY in 2025.

Earnings per Share (EPS) of R&G PharmaStudies Co changed from 1.45 CNY to 1.42 CNY, representing a -2.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) R&G PharmaStudies Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — R&G PharmaStudies Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — R&G PharmaStudies Co